ORAL ONCOLOGY

ORAL ONCOLOGY

ORAL ONCOL
影响因子:3.9
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:ENGLAND
出版社:Elsevier Ltd
发刊时间:1997
发刊频率:Monthly
收录数据库:SCIE/Scopus收录
ISSN:1368-8375

期刊介绍

Oral Oncology is an international interdisciplinary journal which publishes high quality original research, clinical trials and review articles, editorials, and commentaries relating to the etiopathogenesis, epidemiology, prevention, clinical features, diagnosis, treatment and management of patients with neoplasms in the head and neck.Oral Oncology is of interest to head and neck surgeons, radiation and medical oncologists, maxillo-facial surgeons, oto-rhino-laryngologists, plastic surgeons, pathologists, scientists, oral medical specialists, special care dentists, dental care professionals, general dental practitioners, public health physicians, palliative care physicians, nurses, radiologists, radiographers, dieticians, occupational therapists, speech and language therapists, nutritionists, clinical and health psychologists and counselors, professionals in end of life care, as well as others interested in these fields.
口腔肿瘤学是一个国际性的跨学科期刊,发表高质量的原创研究、临床试验和综述文章、社论和评论,涉及头颈部肿瘤的发病机理、流行病学、预防、临床特征、诊断、治疗和管理。口腔肿瘤学是头颈外科医生、放射和内科肿瘤学家、颌面外科医生、耳鼻喉科医生、整形外科医生、病理学家、科学家、口腔医学专家、特殊护理牙医、牙科护理专业人员、全科牙科医生、公共卫生医生、姑息治疗医生、护士、放射科医生、放射技师、营养师、职业治疗师、言语和语言治疗师、营养师、临床和健康心理学家和顾问、临终护理专业人员、以及对这些领域感兴趣的其他人。
年发文量 208
国人发稿量 38.17
国人发文占比 0.18%
自引率 -
平均录取率0
平均审稿周期 平均3月
版面费 US$4080
偏重研究方向 医学-牙科与口腔外科
期刊官网 http://www.journals.elsevier.com/oral-oncology/
投稿链接 https://www.editorialmanager.com/OO

期刊高被引文献

Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2018.11.012
Obesity and genes related to lipid metabolism predict poor survival in oral squamous cell carcinoma.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.12.006
Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.11.028
Evidence for the approach to the diagnostic evaluation of squamous cell carcinoma occult primary tumors of the head and neck.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.11.020
A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.09.022
Accuracy of magnetic resonance imaging in evaluating the depth of invasion of tongue cancer. A prospective cohort study.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.01.021
Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.12.010
Impact of gender on the association between marital status and head and neck cancer outcomes.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2018.12.009
Comparative effectiveness of primary radiotherapy versus surgery in elderly patients with locally advanced oropharyngeal squamous cell carcinoma.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.11.004
Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.03.007
From reactive to proactive tube feeding during chemoradiotherapy for head and neck cancer: A clinical prediction model-based approach.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.11.031
Optimizing the cumulative cisplatin dose during radiotherapy in nasopharyngeal carcinoma: Dose-effect analysis for a large cohort.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2018.12.028
Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.008
Immunohistochemical quantification of partial-EMT in oral cavity squamous cell carcinoma primary tumors is associated with nodal metastasis.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104458
Elective neck dissection for salvage laryngectomy: A systematic review and meta-analysis.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.07.008
Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.07.001
Efficacy of head and neck computed tomography for skeletal muscle mass estimation in patients with head and neck cancer.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.009
Establishment of syngeneic murine model for oral cancer therapy.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.026
Lymph node staging systems in oral squamous cell carcinoma: A comparative analysis.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.08.002
Clinically node-negative head and neck mucosal melanoma: An analysis of current treatment guidelines & outcomes.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.03.017
Assessment of oral health-related quality of life instruments for oral submucous fibrosis: A systematic review using the COnsensus-based Standards for the selection of health Measurement Instruments (COSMIN) checklist.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.04.009
Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.09.004
Effect of local treatment for metastasis and its sequence with chemotherapy on prognosis of post-treatment metastatic nasopharyngeal carcinoma patients.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.03.015
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal?
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.04.006
The efficacy of neutron radiation therapy in treating salivary gland malignancies.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2018.11.006
Patterns of EBV-positive cervical lymph node involvement in head and neck cancer and implications for the management of nasopharyngeal carcinoma T0 classification.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.01.012
Long-term survival and late toxicities of elderly nasopharyngeal carcinoma (NPC) patients treated by high-total- and fractionated-dose simultaneous modulated accelerated radiotherapy with or without chemotherapy.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2018.12.008
Locally advanced non-melanomatous skin cancer: Contemporary radiotherapeutic management.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104443
Development of a cytology-based multivariate analytical risk index for oral cancer.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.02.011
Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.007
A three-gene expression signature associated with positive surgical margins in tongue squamous cell carcinomas: Predicting surgical resectability from tumour biology?
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.05.020
Skeletal muscle mass is an imaging biomarker for decreased survival in patients with oropharyngeal squamous cell carcinoma.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104519
Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.018
Construction of a comprehensive nutritional index and its correlation with quality of life and survival in patients with nasopharyngeal carcinoma undergoing IMRT: A prospective study.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.09.014
Electrochemotherapy as palliative treatment in patients with advanced head and neck tumours: Outcome analysis in 93 patients treated in a single institution.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.03.016
Sex disparities in salivary malignancies: Does female sex impact oncological outcome?
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.05.017
Lack of efficacy of neoadjuvant chemotherapy in adult patients with maxillo-facial high-grade osteosarcomas: A French experience in two reference centers.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.011
Atorvastatin increases oxidative stress and inhibits cell migration of oral squamous cell carcinoma in vitro.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.01.025
The efficacy of chemotherapy in survival of stage II nasopharyngeal carcinoma.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104520
Breakthrough pain in patients with head & neck cancer. A secondary analysis of IOPS MS study.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.06.006
Endoscopic-assisted maxillectomy: Operative technique and control of surgical margins.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.04.002
Oral tongue cancer in a patient with hereditary nonpolyposis colorectal cancer: A case report and review of the literature.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.03.008
Altered-fractionation radiotherapy improves local control in early-stage glottic carcinoma: A systematic review and meta-analysis of 1762 patients.
来源期刊:Oral oncologyDOI:10.1016/J.ORALONCOLOGY.2019.04.007
A comparative study between submandibular-facial artery island flaps (including perforator flap) and submental artery perforator flap: A novel flap in oral cavity reconstruction.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104446
Navigation-guided osteotomies improve margin delineation in tumors involving the sinonasal area: A preclinical study.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104463
Two for the price of one: Prevalence, demographics and treatment implications of multiple HPV mediated Head and Neck Cancers.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104475
Associations between pre-, post-, and peri-operative variables and health resource use following surgery for head and neck cancer.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.02.004
Oral melanomas in HIV-positive patients: Report of two cases and review of the literature.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.07.018
Sanctuary site central nervous system relapse-refractory DLBCL responding to nivolumab and lenalidomide.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.04.010
Increased risk of head and neck cancer in Agent Orange exposed Vietnam Era veterans.
来源期刊:Oral oncologyDOI:10.1016/j.oraloncology.2019.104483

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
87.02%18.71%-0.74%

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q1区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
DENTISTRY, ORAL SURGERY & MEDICINE
Q1

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学2区
DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科
2区
ONCOLOGY 肿瘤学
3区
2023年12月升级版
医学2区
DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科
2区
ONCOLOGY 肿瘤学
3区
2022年12月旧的升级版
医学2区
DENTISTRY, ORAL SURGERY & MEDICINE 牙科与口腔外科
1区
ONCOLOGY 肿瘤学
2区